Up-regulation of hypoxia-inducible factor-1α is not sufficient for hypoxic/anoxic p53 induction

Cancer Research

Volumn 58, Issue 24, 1998, Pages 5678-5680

  Wenger, Roland H ^a,b   Camenisch, Gieri ^a   Desbaillets, Isabelle ^a   Chilov, Dmitri ^a   Gassmann, Max ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b Physikalisch Chemisches I der U Z   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DEFEROXAMINE; PROTEIN P53;

ARTICLE; CELL HYPOXIA; GENE EXPRESSION; GENE INDUCTION; HUMAN; HUMAN CELL; IRON CHELATION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ANIMALS; ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR; CELL HYPOXIA; DEFEROXAMINE; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MICE; NUCLEAR PROTEINS; RECEPTORS, ARYL HYDROCARBON; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0032535077     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Sutherland, R. M. Cell and environment interactions in tumor microrcgions: the multicell spheroid model. Science (Washington DC), 2-10: 177-184, 1988.
2. Wenger, R. H., and Gassmann, M. Oxygen(es) and the hypoxia-inducible factor-1. Biol. Chem., 378: 609-616, 1997.
3. Graeber, T. G., Peterson, J. F., Tsai, M-, Monica, K., Fomace, A. J., Jr., and Giaccia, A. J. Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status. Mol. Cell. Biol., 14: 6264-6277, 1994.
4. Graeber, T. G., Osmanian, C., Jacks, T., Housman, D. E., Koch, C. J., Lowe, S. W., and Giaccia, A. J. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature (Lond.), 379: 88-91, 1996.
5. Dameron, K. M., Volpert, O. V., Tainsky, M. A., and Bouck, N. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science (Washington DC), 265: 1582-1584, 1994.
6. Mukhopadhyay, D., Tsiokas, L., and Sukhatme, V. P. Wild-type p53 and v-Src exert opposing influences on human vascular endothelial growth factor gene expression. Cancer Res., 55: 6161-6165, 1995.
7. Agani, F., Kirsch, D. G., Friedman, S. L., Kastan, M. B., and Semenza, G. L. p53 does not repress hypoxia-induced transcription of the vascular endothelial growth factor gene. Cancer Res., 57: 4474-4477, 1997.
8. Salceda, S., and Caro, J. Hypoxia-inducible factor lot (HIF-1α) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J. Biol. Chem., 272: 22642-22647, 1997.
9. Huang, E. L., Gu, J., Schau, M., and Bunn, H. F. Regulation of hypoxia-inducible factor lot is mediated by an oxygen-dependent domain via the ubiquitin-proteasome pathway. Proc. Natl. Acad. Sci. USA, 95: 7987-7992, 1998.
10. 2 homeostasis by hypoxia-inducible factor 1α. Genes Dev., 12: 149-162, 1998.
11. Ryan, H. E., Lo, J., and Johnson, R. S. HIF-1α is required for solid tumor formation and embryonic vascularization. EMBO J., 17: 3005-3015, 1998.
12. Carmeliet, P., Dor, Y., Herbert, J. M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P., Koch, C. J., Ratcliffe, P., Moons, L., Jain, R. K., Collen, D., and Keshet, E. Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature (Lond.), 39-1: 485-490, 1998.
13. An, W. G., Kanekal, M., Simon, M. C., Maltepe, E., Blagosklonny, M. V., and Neckers, L. M. Stabilization of wild-type p53 by hypoxia-inducible factor lot. Nature (Lond.), 392: 405-408, 1998.
14. Wenaer, R. H., and Gassmann, M. Little difference. Nature (Lond.), 380: 100, 1996.
15. Gradin, K., McGuire, J., Wenger, R. H., Kvietikova, I., Whitelaw, M. L., Toftgård, R., Tora, L., Gassmann, M., and Poellinger, L. Functional interference between hypoxia and dioxin signal transduclion pathways: competition for recruitment of the Arnt transcription factor. Mol. Cell. Biol., 16: 5221-5231, 1996.
16. Numayama-Tsuruta, K., Kobayashi, A., Sogawa, K., and Fujii-Kuriyama, Y. A point mutation responsible for defective function of the aryl-hydrocarbon-receptor nuclear translocator in mutant Hepa-1c1c7 cells. Eur. J. Biochem., 246: 486-495, 1997.
17. Maltepe, E., Schmidt, J. V., Baunoch, D., Bradfield, C. A., and Simon, M. C. Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT. Nature (Lond.), 356: 403-407, 1997.
18. Rolfs, A., Kvietikova, L., Gassmann, M., and Wenger, R. H. Oxygen-regulated transferrin expression is mediated by hypoxia-inducible factor-1. J. Biol. Chem., 272: 20055-20062, 1997.
19. Camenisch, G., Tini, M., Chilov, D., Kvietikova, I., Srinivas, V., Caro, J., Spielmann, P., Wenger, R. H., and Gassmann, M. General applicability of chicken egg yolk antibodies: the performance of IgY immunoglobulins raised asainst the hypoxiainducible factor-1α. FASEB J., in press, 1999.
20. Blagosklonny, M. V., An, W. G., Romanova, L. Y., Trepel, J., Fojo, T., and Neckers, L. p53 inhibits hypoxia-inducible factor-stimulated transcription. J. Biol. Chem., 273: 11995-11998, 1998.